Mody, Freny Vaghaiwalla
Goyal, Ravi K. http://orcid.org/0000-0003-1632-036X
Ajmera, Mayank
Davis, Keith L.
Amin, Alpesh N.
Funding for this research was provided by:
Amgen
Article History
Accepted: 19 May 2024
First Online: 1 August 2024
Declarations
:
: This study was funded by Amgen Inc.
: F.V.M. and A.N.A. were consultants for Amgen for the study design phase but were not paid for the development, writing, or review of this manuscript. A.N.A. is a PI or co-I of clinical trials sponsored by NIH/NIAID, NeuroRx Pharma, Pulmotect, Blade Therapeutics, Novartis, Takeda, Humanigen, Eli Lilly, PTC Therapeutics, OctaPharma, Fulcrum Therapeutics, Alexion; Speaker and/or consultant for Pfizer, Salix, Alexion, AstraZeneca, Bayer, Ferring, Seres, Spero, Eli Lilly, Nova Nordisk, Gilead, Renibus, GSK, Dexcom, Reprieve, HeartRite, Aseptiscope, having nothing to do with this project. R.K.G. and K.L.D. are employed by RTI Health Solutions, a nonprofit research institute contracted by Amgen Inc. to conduct this research. MA was an employee of RTI Health Solutions at the time of the conduct of this research. All authors approved the final manuscript.
: All authors contributed to the study conception and design. Material preparation, data collection, and analysis were performed by R.K.G., M.A., and K.L.D. The first draft of the manuscript was written by F.V.M. and R.K.G. and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
: Qualified researchers may request data from Amgen clinical studies. Complete details are available at the following: .
: The RTI Institutional Review Board (IRB) waived full IRB review or informed consent from patients because of the use of deidentified patient data.
: Not applicable.
: Not applicable.
: Not applicable.